Request Information

News

Media coverage of Auris Health

Contact us

Auris Receives High Valuation

Auris Health, formerly known as Auris Surgical Robotics, finds itself in good company with other billion-dollar valuation startups, all working to revolutionize healthcare in 2018.

Continue Reading

Auris's Monarch Platform featured in The Economist

Even when Auris Health, Inc., formerly known as Auris Surgical Robotics, was in stealth mode, it was featured as one of the new surgical robots about to enter the surgical suites. Dr. Fred Moll, CEO of Auris, is a well known as a pioneer in medical robotics. When Dr. Moll began developing the Monarch Platform, there was much speculation about his work. Lung cancer was identified as a key disease state that Auris was going to tackle.

Continue Reading

Dr. Michael Machuzak Interviewed on Auris's Technology

In this video interview at CHEST's Annual Meeting, Dr. Machuzak of the Cleveland Clinic summarizes his experience using the Monarch Platform in Auris's study, REACH Assessment: Advanced Bronchoscopic Techniques. According to Machuzak, Auris's robotic bronchoscope was compared to other standard flexible bronchoscopes, and the results were encouraging.

Continue Reading

Secretive Surgical Robotics Company Raises $280 Million

Auris Health, formerly known as Auris Surgical Robotics, is featured in the article for raising an unprecedented amount of funding in 2017. According to this article, Auris raised $280 million in a Series D round. After raising a large investment, Auris has remained silent about its work on the Monarch Platform, creating great intrigue in the financial media.

Continue Reading

Auris in TechCrunch

Auris is featured in this TechCrunch article not only for its impressive Series D funding but also for the opportunity it brings with its focus on the lung cancer market. Lung cancer claims more victims than prostate, breast, and colon cancer combined. It remains a very dangerous form of cancer because a diagnosis often comes late, when the cancer has already spread.

Continue Reading

Auris Health's $280 Million Financing in WSJ

Auris Health’s $280 million Series D financing made headlines in the Wall Street Journal. According to the article, the company’s financing is part of a significant increase in medical-technology venture funding. It also spoke of Auris CEO Dr. Fred Moll, a robotic-surgery pioneer and serial entrepreneur with much success from previous companies he founded.

Continue Reading

Auris Achieves High Valuation

Auris joined the unicorn ranks in 2017 for reaching billion-dollar valuation. According to the article, 53 venture capital-backed companies reached billion-dollar valuations last year. Auris is the only company listed for robotics, medical robotics or endoscopy robotics.

Continue Reading

Why Auris is Fierce

Even when Auris Health, Inc., formerly known as Auris Surgical Robotics, was in stealth mode, it was recognized as a fierce company, thanks to the innovation and experience of Auris CEO, Dr. Fred Moll. The serial entrepreneur and innovator has long contributed to the robotics space.

Continue Reading

Auris Part of the Uptick in Robotics Startups

This article featured Auris Health, formerly known as Auris Surgical Robotics, for how well-funded it is by venture capitalists. According to the article, one of Auris’s major investors, Lux Capital, made the list for most active VC investors in robotics from 2011 – 2016. Additionally, Auris ranked at the top for being the most-well funded robotics company from 2011 – 2016.

Continue Reading

10 Robotic Surgery Companies

Stealthy Auris Health, Inc., formerly known as Auris Surgical Robotics, made the list of 10 robotic surgery companies to be watched. According to the article, robotic technology may be a less invasive approach with higher success rates, in comparison to today’s more traditional approaches. Auris was specifically mentioned for its impressive funding and 2016 FDA clearance for its robotic endoscopy system, ARES (Auris Robotic Endoscopy System).

Continue Reading